CHINA BEST (00370) Chinese stock ticker symbol will be changed to "Hong Kong Siasun Robot & Automation"
Kok Hwa (00370) announced that the Registrar of Companies in Bermuda has issued a... to the company on May 6, 2025.
CHINA BEST (00370) announces that the Registrar of Companies in Bermuda issued a Certificate of Change of Name Registration to the company on May 6, 2025, confirming the change of name from "China Best Group Holding Limited" to "Hong Kong Robotics Group Holding Limited". The Registrar of Companies in Bermuda also issued a second Name Registration Certificate on May 6, 2025, confirming the adoption of the Chinese name "Siasun Robot&Automation Group Holding Limited" as the company's second name in Bermuda, replacing its old Chinese name "CHINA BEST Group Holding Limited" (adopted by the company for identification purposes and not registered in Bermuda). The company also obtained a Certificate of Change of Name Registration for Non-Hong Kong Companies on May 27, 2025, from the Registrar of Companies in Hong Kong, confirming that the English name "Hong Kong Robotics Group Holding Limited" and the Chinese name "Siasun Robot&Automation Group Holding Limited" have been registered in Hong Kong in accordance with Section 16 of the Companies Ordinance (Chapter 622) of Hong Kong.
Starting from 9:00 am on June 6, 2025, the English stock short name for trading on the Stock Exchange will be changed from "CHINA BEST" to "HK ROBOTICS", while the Chinese stock short name will be changed from "CHINA BEST" to "Siasun Robot&Automation". The stock code of the company on the Stock Exchange remains unchanged, still "370".
Related Articles

Huisean Shares (02127) issued 146 million subscription shares on May 19th.

MNSO (09896) spent 21.99 million USD to repurchase 51,200 shares on June 3rd.

Hansoh Pharma (03692): Apatinib Mesylate Tablets Approved for Listing by the UK Medicines and Healthcare products Regulatory Agency.
Huisean Shares (02127) issued 146 million subscription shares on May 19th.

MNSO (09896) spent 21.99 million USD to repurchase 51,200 shares on June 3rd.

Hansoh Pharma (03692): Apatinib Mesylate Tablets Approved for Listing by the UK Medicines and Healthcare products Regulatory Agency.

RECOMMEND

U.S. Doubles Steel and Aluminum Tariffs to 50%, Sparking Global Backlash and Economic Concerns
03/06/2025

Humanoid Robots Are “Rushing” to Market, While Users Urge Clarification of Demand and Warn Against a “Technology Bubble”
03/06/2025

Wall Street Adopts Defensive Stance Toward 30-Year U.S. Treasuries: Avoidance or Shorting
03/06/2025